文献速递免疫规划传染病防控与疫情报告

基于比利时血清流行率数据推断风疹暴发风险

Inferring rubella outbreak risk from seroprevalence data in Belgium.
PubMed 文献 · Vaccine · 2016-11-10

本文利用2006年比利时风疹血清流行率数据和疫苗接种覆盖率数据,结合文献综述获得的原发性和继发性疫苗失败信息,采用先前开发的方法识别高暴发潜力的地理区域,评估风疹暴发风险。估计比利时风疹暴发风险为低,但维持高水平免疫和监测对于避免未来暴发至关重要。

要点

  • 风疹约50%病例无或仅有少量临床症状,孕期早期感染可导致流产、中枢神经系统缺陷或先天性风疹综合征。
  • 比利时风疹暴发风险估计为低。
  • 维持高水平免疫和监测对于避免未来风疹暴发至关重要。

核心结论

  • 比利时风疹暴发风险估计为低,但维持高水平免疫和监测对于避免未来暴发至关重要。

研究设计与样本

  • 基于2006年比利时风疹血清流行率数据和疫苗接种覆盖率数据,结合文献综述获得的原发性和继发性疫苗失败信息,采用先前开发的方法识别高暴发潜力的地理区域。

主要发现

  • 风疹通常是一种轻微疾病,约50%的病例没有或只有少量临床症状。
  • 在高收入国家,含风疹抗原疫苗引入后风疹发病率急剧下降。
  • 近期欧洲高疫苗接种覆盖率国家发生大规模腮腺炎暴发,提供疫苗诱导免疫特异性减弱和原发性疫苗失败的证据。
  • 近期麻疹暴发影响疫苗接种覆盖率不理想的人群,强调维持高疫苗接种覆盖率的重要性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rubella is usually a mild disease for which infections often pass by unnoticed. In approximately 50% of the cases, there are no or only few clinical symptoms. However, rubella contracted during early pregnancy could lead to spontaneous abortion, to central nervous system defects, or to one of a range of other serious and debilitating conditions in a newborn such as the congenital rubella syndrome. Before the introduction of mass vaccination, rubella was a common childhood infection occurring all over the world. However, since the introduction of rubella antigen-containing vaccines, the incidence of rubella has declined dramatically in high-income countries. Recent large-scale mumps outbreaks, one of the components in the combined measles-mumps-rubella vaccine, occurring in countries throughout Europe with high vaccination coverage, provide evidence of pathogen-specific waning of vaccine-induced immunity and primary vaccine failure. In addition, recent measles outbreaks affecting populations with suboptimal vaccination coverages stress the importance of maintaining high vaccination coverages. In this paper, we focus on the assessment of rubella outbreak risk using a previously developed method to identify geographic regions of high outbreak potential. The methodology relies on 2006 rubella seroprevalence data and vaccination coverage data from Belgium and information on primary and secondary vaccine failure obtained from extensive literature reviews. We estimated the rubella outbreak risk in Belgium to be low, however maintaining high levels of immunisation and surveillance are of utmost importance to avoid future outbreaks.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Abrams S, Kourkouni E, Sabbe M, et al. Inferring rubella outbreak risk from seroprevalence data in Belgium. Vaccine. 2016. PMID: 27840011. doi:10.1016/j.vaccine.2016.10.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。